Riskpilot← Back to searchSign inGet full accessHägges Läkarkonsult AB
ABActiveOrg 5566659453Kompassgatan 51Medical specialists activities · NACE 8622Est. 20040 employees
Revenue 2024
SEK 1,2M
+44% vs 2023
EBITDA margin
69.9%
+77% vs 2023
Equity ratio
70.1%
Financial strength
Net profit 2024
SEK 659K
+84% vs 2023
| Revenue | SEK 1,2M | +44% |
| EBITDA | SEK 864K | +77% |
| Net profit | SEK 659K | +84% |
| Total assets | SEK 1,4M | +65% |
| Equity | SEK 966K | +98% |
| Employees | 0 | — |
Legal name
Hägges Läkarkonsult AB
Org number
5566659453
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
4 september 2004
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva hyrläkarverksamhet, konsultationer inom läkaryrket, hålla föreläsningar samt äga och förvalta värdepapper och fastigheter samt därmed förenlig verksamhet.
Address
Kompassgatan 51
Phone
+463534040
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 918 | 898 | 877 | 856 | 1 236 |
| Staff expenses | — | — | −150 | −123 | −129 |
| EBITDA | 636 | 564 | 530 | 489 | 864 |
| Depreciation & amort. | −0 | −73 | −76 | −76 | −76 |
| EBIT | 636 | 491 | 454 | 413 | 788 |
| Net financials | 6 | 9 | 8 | 21 | 29 |
| Profit before tax | 641 | 459 | 458 | 455 | 838 |
| Tax | −139 | −99 | −82 | −97 | −179 |
| Net profit | 502 | 360 | 377 | 358 | 659 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 072 | 945 | 869 | 837 | 1 377 |
| Equity | 790 | 650 | 529 | 487 | 966 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 282 | 254 | 296 | 326 | 408 |
| Total debt | 282 | 254 | 296 | 326 | 408 |
EBITDA margin
69.9%
This company
15.8%
Market median
+342% vs market
20202024
Equity ratio
70.1%
This company
38.2%
Market median
+84% vs market
20202024
Return on equity
68.2%
This company
18.4%
Market median
+271% vs market
20202024
Net profit margin
53.3%
This company
8.1%
Market median
+558% vs market
20202024
Asset turnover
0.90×
This company
1.12×
Market median
+20% vs market
20202024
Debt / equity
0.43×
This company
0.62×
Market median
+31% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2023 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Hägges Läkarkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Magnus Hägge | Board of Directors | 0 companies |
| Annika Helen Hägge | Deputy Board Member | 0 companies |
| Per-Erik Hägge | Deputy Board Member | 0 companies |